Generation Bio Inc. (GBIO): Price and Financial Metrics Recent IPO
Generation Bio Inc. (GBIO) Recent IPO
Today's Latest Price: $37.79 USD
Updated Nov 24 4:00pm
Add GBIO to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 240 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
GBIO Stock Price Chart Interactive Chart >
GBIO Price/Volume Stats
| Current price | $37.79 | 52-week high | $38.00 |
| Prev. close | $35.28 | 52-week low | $17.00 |
| Day low | $35.16 | Volume | 97,900 |
| Day high | $38.00 | Avg. volume | 173,685 |
| 50-day MA | $28.19 | Dividend yield | N/A |
| 200-day MA | $0.00 | Market Cap | 1.76B |
Generation Bio Inc. (GBIO) Company Bio
Generation Bio Co. is a genetic medicines company focuses on creating a new class of gene therapy to provide durable and redosable treatment for patients suffering from both rare and prevalent diseases. Its non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA; a novel cell-targeted lipid nanoparticle delivery system, or ctLNP; and an established, scalable capsid-free manufacturing process. The company was founded by Mark D. Angelino, Jason P. Rhodes, and Robert M. Kotin in 2016 and is headquartered in Cambridge, MA.
Loading social stream, please wait...